Compugen (CGEN) Net Margin (2009 - 2026)

Compugen recorded quarterly Net Margin of 351.98% in Q1 2026, up 12.93% quarter-over-quarter from 311.69% in Q1 2025, and up 4029.0% year-over-year from 8.52% in Q1 2025.

Compugen's Net Margin history runs 2 years deep, the most recent figure standing at 351.98% for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 351.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 351.98%
Dec 31, 2025 84.26%
Sep 30, 2025 -364.83%
Jun 30, 2025 -1,719.49%
Mar 31, 2025 311.69%
Dec 31, 2024 -415.84%
Sep 30, 2024 60.03%
Jun 30, 2024 -248.03%
Mar 31, 2024 283.74%
Dec 31, 2023 29.03%
Dec 31, 2022 -41.23%
Dec 31, 2020 -428.15%
Sep 30, 2018 -39.88%
Dec 31, 2016 -16,022.64%
Sep 30, 2016 -11,115.71%
Jun 30, 2016 -1,333.06%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -5.68%
Sep 30, 2015 -2,944.10%
Jun 30, 2015 -3,052.91%
Mar 31, 2015 -1,197.47%
Dec 31, 2014 -22.62%
Sep 30, 2014 -314.03%
Jun 30, 2014 -111.97%
Mar 31, 2014 -88.98%
Dec 31, 2013 -164.96%
Sep 30, 2013 -298.24%
Jun 30, 2013 -13,813.64%
Mar 31, 2013 -2,082.72%
Dec 31, 2012 -4,009.70%
Sep 30, 2012 -3,250.00%
Dec 31, 2010 -1,210.53%
Jun 30, 2010 -122.25%
Mar 31, 2010 -2,174.40%
Dec 31, 2009 -8.00%
Sep 30, 2009 -28.13%